Global Healthcare Cold Chain Logistics Market Report & Forecast 2024-2032

Global Healthcare Cold Chain Logistics Market Report & Forecast 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A586
Buy Now

Healthcare Cold Chain Logistics Market Size:

The global healthcare cold chain logistics market size reached USD 17.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 23.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The market is expanding due to rising global demand for biopharmaceuticals that are sensitive to temperature, growing vaccine industry, increasing clinical trials, and technological developments in refrigeration and monitoring systems that guarantee the safe distribution of pharmaceuticals.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
USD 17.6 Billion
Market Forecast in 2032
USD 23.0 Billion
Market Growth Rate (2024-2032) 2.9%


Healthcare Cold Chain Logistics Market Analysis:

  • Major Market Drivers: The growing demand for biopharmaceuticals, vaccines, and customized medicine that requires sophisticated cold chain logistics to ensure product efficacy and safety of the products is propelling the market growth. Moreover, technical advancements like enhanced refrigeration technologies and Internet of Things-enabled monitoring systems boost cold chain logistics' dependability and efficiency while lowering the risk of spoilage and guaranteeing adherence to strict regulations.
  • Key Market Trends: The market is expanding due to the integration of machine learning and artificial intelligence for cold chain operations optimization. These technologies enable better predictive analytics and real-time monitoring, which improve operational efficiency and reduce wastage. Besides, the trend toward outsourcing cold chain logistics to specialized third-party providers is growing, allowing healthcare companies to focus on their core activities while leveraging the expertise and resources of logistics specialists.
  • Geographical Trends: Asia-Pacific region is the leading market due to the growing pharmaceutical output, increasing healthcare investments, and growing public health awareness. In addition, the China and India market are also emerging due to the increased need for cold chain logistics services. Moreover, the North American region is experiencing rapid growth due to its established cold chain logistics networks, strict regulatory requirements, and advanced healthcare infrastructure.
  • Competitive Landscape: Some of the major healthcare cold chain logistics companies include Amerisource Bergen Corporation (World Courier), Deutsche Post DHL Group, FedEx Corporation Services, Inc., United Parcel Service of America, Inc., Kuehne + Nagel International AG, Cavalier Logistics, Inc., DB Schenker, Life ConEx, American Airlines Cargo, Continental Group, Marken Ltd. etc., among many others.
  • Challenges and Opportunities: Compliance with diverse and stringent regulatory requirements poses a significant challenge, as non-compliance can result in penalties and damage to reputation while adapting to varying regional conditions and regulatory environments, which requires flexibility and innovation in logistics solutions. On the other hand, the healthcare cold chain logistics market recent opportunities allow companies to differentiate themselves by providing superior compliance and quality assurance while expanding healthcare infrastructure in cold chain logistics services.
     

Healthcare Cold Chain Logistics Market

Healthcare Cold Chain Logistics Market Trends:

 Increasing Demand for Biopharmaceuticals

The surge in the biopharmaceutical sector is a critical driver for the healthcare cold chain logistics market. According to the IQVIA Institute the biopharmaceutical market will grow to between USD 1.750 and 1.780 Trillion by 2026, up nearly USD 350 Billion from the 2021 figure of USD 1.423 Trillion. This increase is primarily driven by the expansion of the market in emerging pharmaceutical countries and developed nations, along with the integration of new technologies. Additionally, biopharmaceuticals are large, complex molecules often derived from biological sources that require stringent temperature control to maintain their efficacy and safety. As the market for these products is expected to expand significantly, the logistics services catering to them must adapt to handle their sensitive nature. This involves sophisticated packaging solutions, real-time temperature monitoring, and specialized transportation methods. Furthermore, the demand for biopharmaceuticals, fueled by their efficacy in treating complex diseases is increasing the need for enhanced cold chain logistics to prevent product degradation during transit, ensuring that these vital medications reach patients in optimal condition, thus creating a positive healthcare cold chain logistics market outlook.

Growth in the Vaccines Market

According to the World Health Organization (WHO), COVID-19 vaccines still represent a significant portion, accounting for 60% of the total global vaccine market volume. The primary high-volume vaccines apart from COVID-19 include seasonal influenza, oral polio, and tetanus-diphtheria vaccines. For instance, measles-rubella (MR) vaccination volumes increased significantly due to the increased catch-up vaccination efforts. This expansion is primarily due to the large investments in vaccine research and the growing global emphasis on vaccination against common and emerging infectious diseases. Furthermore, cold chain logistics is essential in this industry as vaccinations frequently need to be kept at a certain temperature to remain effective. Moreover, temperature changes can damage the integrity of vaccinations, resulting in a loss of efficacy and ultimately, an ineffective immunization campaign. Moreover, as evident in the healthcare cold chain logistics market forecast, the escalating need of vaccine distribution especially in underdeveloped regions that face extreme climatic challenges will continue to propel the market.

Expansion of the Global Clinical Trials Market

The National Library of Medicine, published data of Clinical Trials Transformation Initiative Aggregate Analysis of ClinicalTrials.gov (AACT) database, focusing on trials (interventional studies) started between 1 January 2000 through 31 December 2020. The analysis included 274,043 registered interventional studies which were characterized as randomized (65%), conducted at a single site (60%), and utilized a parallel-group design (56%). Additionally, 65% of the trials were funded by various other sources such as individuals, universities, and community organizations, and 55% involved drug interventions. As of May 2022, ClinicalTrials.gov had over 400,000 registered studies from 220 countries, including observational and interventional research. Furthermore, clinical trials require the transportation of temperature-sensitive materials like blood, tissue, or experimental compounds that are essential to medical research and development (R&D). These samples need to be handled carefully and transported at regulated temperatures to guarantee that the trial findings are legitimate. As a result, the demand for dependable and effective cold chain logistics is rising due to the global expansion of clinical trials. These logistics providers must be able to handle the challenges of transporting sensitive clinical materials across a variety of geographic and climatic conditions, which is increasing the overall healthcare cold chain logistics market revenue.

Healthcare Cold Chain Logistics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on product and segment.

Breakup by Product:

Healthcare Cold Chain Logistics Market By Product

  • Clinical Trial Materials
  • Vaccines
  • Biopharmaceuticals
     

Vaccines accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes clinical trial materials, vaccines, and biopharmaceuticals. According to the report, vaccines represented the largest segment.

Vaccines dominate the market due to the necessity of maintaining strict temperature controls to ensure vaccination effectiveness throughout storage and transit. Similarly, vaccines are extremely delicate biological materials, and they must be refrigerated constantly to avoid the deterioration of their active ingredients, which is crucial for maintaining public health. Furthermore, the development of novel vaccines due to the increasing health concerns and global vaccination campaigns fuel the dependable and effective healthcare cold chain logistics demand especially in developing regions. According to the International Air Transport Association (IATA), India is exporting approximately two-thirds of its vaccine output, and the remaining one-third is utilized within the country, with the universal immunization programme (UIP) facilitating nationwide distribution. This increasing exportation is catalyzing the market due to the growing need for continuous vaccines refrigeration technology and apparatus, such as customized packaging and temperature-monitoring systems to prevent the degradation of their active components.

Breakup by Segment:

  • Transportation
  • Packaging
  • Instrumentation
     

Packaging holds the largest share of the industry

A detailed breakup and analysis of the market based on the segment have also been provided in the report. This includes transportation, packaging, and instrumentation. According to the report, packaging accounted for the largest market share.

Packaging plays a critical role in maintaining the integrity, efficacy, and safety of temperature-sensitive pharmaceuticals and biologics. Advanced packaging solutions, including insulated containers and temperature-controlled boxes, are vital for the successful transportation of products such as vaccines, biopharmaceuticals, clinical trial materials, and biologics that require strict temperature regulation throughout the distribution chain. The demand for robust packaging solutions is driven by the increasing complexity of new pharmaceutical products, stringent regulatory requirements, and the global expansion of pharmaceutical companies into new markets requiring reliable logistics solutions. As healthcare continues to globalize and the pipeline of temperature-sensitive products expands, the packaging sector within cold chain logistics is growing thus impacting the healthcare cold chain logistics market growth. For instance, on 3 June 2024, the Deutsche Post DHL Group (DHL) supply chain enhances pharma logistics in France. DHL supply chain will manage picking and packing, warehousing, inventory handling, and order fulfillment at three principal locations in France, Amilly Distribution, Croissy-Beaubourg, and Saint-Loubes. This collaboration significantly impacts the French market and strategically positions DHL within the pharmaceutical sector.

Breakup by Region:

Healthcare Cold Chain Logistics Market By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
     

Asia Pacific leads the market, accounting for the largest healthcare cold chain logistics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, and the rest of the world. According to the report, Asia Pacific was the largest regional market for healthcare cold chain logistics.

According to the healthcare cold chain logistics market overview, the Asia Pacific region emerges as the largest segment, primarily due to its robust pharmaceutical growth, increasing healthcare expenditures, and rising demand for quality healthcare products. Additionally, the proliferation of biopharmaceuticals and the expansion of clinical trial activities further amplify the need for sophisticated cold chain solutions in this region. Moreover, the Asia Pacific benefits from a growing middle-class population and enhanced healthcare infrastructure, which are key to the development of cold chain systems. Furthermore, government initiatives across various countries to improve healthcare access and regulatory compliance regarding the distribution of temperature-sensitive products also significantly contribute to the dominance of the Asia Pacific in the global healthcare cold chain logistics market. For instance, on 21 March 2024, UPS, a leading global logistics company, increased its investment commitments in the Asia Pacific region to over $250 Million since early 2023. This includes a recent agreement with The Luzon International Premiere Airport Development Corporation (LIPAD) to enhance its operations at Clark Airport (CRK) in the Philippines. This expansion will allow UPS to further develop its comprehensive suite of services, including integrated express, supply chain, and healthcare logistics.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the healthcare cold chain logistics industry include Amerisource Bergen Corporation (World Courier), Deutsche Post DHL Group, FedEx Corporation Services, Inc., United Parcel Service of America, Inc., Kuehne + Nagel International AG, Cavalier Logistics, Inc., DB Schenker, Life ConEx, American Airlines Cargo, Continental Group, Marken Ltd. etc.

    (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
     
  • At present, key players are implementing strategies to strengthen market growth and enhance service delivery. Additionally, the healthcare cold chain logistics market recent developments include investment in advanced technologies, such as IoT-enabled tracking systems and temperature-monitoring solutions, to ensure the integrity and timely delivery of sensitive healthcare products. Additionally, companies are focusing on sustainability by integrating eco-friendly practices in their operations to reduce carbon footprints and appeal to a broader base of environmentally conscious stakeholders. Besides, partnerships and collaborations with biopharmaceutical companies are aiming to optimize the distribution process for vaccines, biologics, and clinical trial materials. These players are expanding their geographical reach by establishing more robust logistics networks in emerging markets, where healthcare needs are rapidly growing. For instance, on 13 July 2023, the DHL supply chain announced a significant commitment of €500 Million toward the strategically vital Latin America market. This funding, which will be deployed by 2028, aims to bolster DHL’s operations across the region. This investment forms a crucial part of DHL Supply Chain's strategic plan to enhance its logistics services in sectors with growing demand, including healthcare, automotive, technology, retail, and e-commerce.


Healthcare Cold Chain Logistics Market News:

  • 10 April 2023, UPS Healthcare launches its first specialized facility in Giessen, Germany. The specialized healthcare logistics center spans 293,000 square foot (27,200 m2) and the facility meets GMP and GDP standards and accommodates over 30,000 pallet positions for various healthcare products, maintaining temperatures of 2C to 8C, 15C to 25C, and as low as -20C degrees.
  • 28 May 2024, the DHL supply chain increases capacity with a new logistics facility at leipzig/halle multi-user campus. The newly established logistics center will provide ample space for clients needing effective logistics solutions in Germany, Europe, or globally. The facility spans 34,000 square meters and represents a state-of-the-art expansion of the company's existing capacities at the multi-user campus in Leipzig/Halle. The DHL supply chain caters to a diverse range of industries and sectors, taking advantage of the region’s excellent transportation links for domestic and international distribution.


Healthcare Cold Chain Logistics Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units Billion USD
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Product
  • Segment
  • Region
Products Covered Clinical Trial Materials, Vaccines, Biopharmaceuticals
Segments Covered Transportation, Packaging, Instrumentation
Regions Covered North America, Europe, Asia Pacific, Rest of the World
Companies Covered Amerisource Bergen Corporation (World Courier), Deutsche Post DHL Group, FedEx Corporation Services, Inc., United Parcel Service of America, Inc., Kuehne + Nagel International AG, Cavalier Logistics, Inc., DB Schenker, Life ConEx, American Airlines Cargo, Continental Group, Marken Ltd. etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the healthcare cold chain logistics market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global healthcare cold chain logistics market.
  • The study maps the leading, as well as the fastest-growing, regional markets.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the healthcare cold chain logistics industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global healthcare cold chain logistics market was valued at USD 17.6 Billion in 2023.

We expect the global healthcare cold chain logistics market to exhibit a CAGR of 2.9% during 2024-2032.

The rising demand for outsourcing operations in the pharmaceutical and biopharmaceutical sector for drugs, vaccines, clinical trial materials, etc., is primarily driving the global healthcare cold chain logistics market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of healthcare cold chain logistics for storing and transporting various temperature-sensitive healthcare products and vaccines across numerous countries.

Based on the product, the global healthcare cold chain logistics market has been segmented into clinical trial materials, vaccines, and biopharmaceuticals. Currently, vaccines hold the majority of the total market share.

Based on the segment, the global healthcare cold chain logistics market can be divided into transportation, packaging, and instrumentation. Among these, packaging currently exhibits a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, and Rest of the World, where Asia Pacific currently dominates the global market.

Some of the major players in the global healthcare cold chain logistics market include Amerisource Bergen Corporation (World Courier), Deutsche Post DHL Group, FedEx Corporation Services, Inc., United Parcel Service of America, Inc., Kuehne + Nagel International AG, Cavalier Logistics, Inc., DB Schenker, Life ConEx, American Airlines Cargo, Continental Group, and Marken Ltd.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Healthcare Cold Chain Logistics Market Report & Forecast 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More